600713 南京医药
已收盘 06-09 15:00:00
资讯
新帖
简况
股市必读：南京医药（600713）6月1日董秘有最新回复
证券之星 · 06-02
股市必读：南京医药（600713）6月1日董秘有最新回复
南京医药：公司2026年3月末股东总数为47,508人
证券之星 · 06-01
南京医药：公司2026年3月末股东总数为47,508人
每周股票复盘：南京医药（600713）拟设并购基金出资不超4.5亿
证券之星 · 05-31
每周股票复盘：南京医药（600713）拟设并购基金出资不超4.5亿
南京医药（600713）披露召开2026年第三次临时股东会提示性公告，5月28日股价下跌0.8%
证券之星 · 05-28
南京医药（600713）披露召开2026年第三次临时股东会提示性公告，5月28日股价下跌0.8%
南京医药（600713）披露拟设立大清并购基金并收购大清生物及科健科技股权，5月26日股价下跌0.59%
证券之星 · 05-26
南京医药（600713）披露拟设立大清并购基金并收购大清生物及科健科技股权，5月26日股价下跌0.59%
每周股票复盘：南京医药（600713）拟出资4.5亿参与设立大清并购基金
证券之星 · 05-24
每周股票复盘：南京医药（600713）拟出资4.5亿参与设立大清并购基金
南京医药（600713）披露召开2026年第三次临时股东会的通知，5月21日股价下跌1.96%
证券之星 · 05-21
南京医药（600713）披露召开2026年第三次临时股东会的通知，5月21日股价下跌1.96%
南京医药最新公告：拟出资不超4.5亿元设立并购基金专项收购大清生物及科健科技股权
证券之星 · 05-21
南京医药最新公告：拟出资不超4.5亿元设立并购基金专项收购大清生物及科健科技股权
南京医药(600713.SH)拟通过并购基金投资生物材料和再生医学领域平台型研发公司
智通财经网 · 05-21
南京医药(600713.SH)拟通过并购基金投资生物材料和再生医学领域平台型研发公司
南京医药（600713）披露终止对外投资公告，5月20日股价下跌2.3%
证券之星 · 05-20
南京医药（600713）披露终止对外投资公告，5月20日股价下跌2.3%
每周股票复盘：南京医药（600713）将召开2025年年度业绩说明会
证券之星 · 05-17
每周股票复盘：南京医药（600713）将召开2025年年度业绩说明会
南京医药（600713）披露召开2025年年度暨2026年第一季度业绩说明会公告，5月14日股价下跌1.13%
证券之星 · 05-14
南京医药（600713）披露召开2025年年度暨2026年第一季度业绩说明会公告，5月14日股价下跌1.13%
每周股票复盘：南京医药（600713）2025年年度股东会顺利召开
证券之星 · 05-10
每周股票复盘：南京医药（600713）2025年年度股东会顺利召开
南京医药（600713）披露2025年年度股东会决议公告，5月8日股价上涨0.94%
证券之星 · 05-08
南京医药（600713）披露2025年年度股东会决议公告，5月8日股价上涨0.94%
每周股票复盘：南京医药（600713）一季度营收138.44亿元
证券之星 · 05-02
每周股票复盘：南京医药（600713）一季度营收138.44亿元
南京医药（600713）2026年一季报简析：净利润同比下降1.57%，盈利能力上升
证券之星 · 05-01
南京医药（600713）2026年一季报简析：净利润同比下降1.57%，盈利能力上升
南京医药（600713）披露增加2026年度日常关联交易预计公告，4月29日股价上涨0.18%
证券之星 · 04-29
南京医药（600713）披露增加2026年度日常关联交易预计公告，4月29日股价上涨0.18%
图解南京医药一季报：第一季度单季净利润同比下降1.57%
证券之星 · 04-29
图解南京医药一季报：第一季度单季净利润同比下降1.57%
每周股票复盘：南京医药（600713）子公司5000万闲置募资买大额存单
证券之星 · 04-19
每周股票复盘：南京医药（600713）子公司5000万闲置募资买大额存单
南京医药（600713）2025年年报简析：营收净利润同比双双增长
证券之星 · 04-12
南京医药（600713）2025年年报简析：营收净利润同比双双增长
加载更多
公司概况
公司名称：
南京医药集团股份有限公司
所属行业：
零售业
上市日期：
1996-07-01
主营业务：
南京医药集团股份有限公司的主营业务是药品配送、批发、零售及医疗器械配送、批发、医药物流服务和互联网药品零售。公司的主要产品是医药批发、医药零售、医药“互联网+”、医药第三方物流服务。公司现居2024年国内医药流通行业规模排名第7位；2025年《财富》中国500强第307位，较上年排名上升11位。公司亦曾荣获“全国医药流通创新示范企业”称号，是第一批“全国供应链创新与应用示范企业”。
发行价格：
5.98
{"stockData":{"symbol":"600713","market":"SH","secType":"STK","nameCN":"南京医药","latestPrice":4.95,"timestamp":1780988400000,"preClose":4.92,"halted":0,"volume":5909640,"delay":0,"changeRate":0.0061,"floatShares":1290000000,"shares":1309000000,"eps":0.4753,"marketStatus":"已收盘","change":0.03,"latestTime":"06-09 15:00:00","open":4.92,"high":4.97,"low":4.89,"amount":29141300,"amplitude":0.0163,"askPrice":4.95,"askSize":1530,"bidPrice":4.94,"bidSize":1068,"shortable":0,"etf":0,"ttmEps":0.4753,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781055000000},"marketStatusCode":5,"adr":0,"adjPreClose":4.92,"symbolType":"stock","openAndCloseTimeList":[[1780968600000,1780975800000],[1780981200000,1780988400000]],"highLimit":5.41,"lowLimit":4.43,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1308892948,"isCdr":false,"pbRate":0.88,"roa":"--","peRate":10.414475,"roe":"2.4%","epsLYR":0.48,"committee":0.024741,"marketValue":6479000000,"turnoverRate":0.0046,"status":0,"floatMarketCap":6385000000},"requestUrl":"/m/hq/s/600713","defaultTab":"news","newsList":[{"id":"2640692929","title":"股市必读：南京医药（600713）6月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640692929","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640692929?lang=zh_cn&edition=full","pubTime":"2026-06-02 02:47","pubTimestamp":1780339631,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，南京医药报收于5.12元，上涨2.2%，换手率0.88%，成交量11.3万手，成交额5723.93万元。董秘最新回复投资者： 董秘您好！请问截止5月28号，公司的股东人数是多少？公司通过定期报告披露季度末股东总数，公司2026年3月末股东总数为47,508人。当日关注点来自交易信息汇总：6月1日主力资金净流入89.45万元，占总成交额1.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200002129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","600713","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640318519","title":"南京医药：公司2026年3月末股东总数为47,508人","url":"https://stock-news.laohu8.com/highlight/detail?id=2640318519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640318519?lang=zh_cn&edition=full","pubTime":"2026-06-01 15:37","pubTimestamp":1780299461,"startTime":"0","endTime":"0","summary":"证券之星消息，南京医药(600713)06月01日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问截止5月28号，公司的股东人数是多少？谢谢南京医药回复：感谢您对公司的关注。公司通过定期报告披露季度末股东总数，公司2026年3月末股东总数为47,508人。谢谢！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100017389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639602324","title":"每周股票复盘：南京医药（600713）拟设并购基金出资不超4.5亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2639602324","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639602324?lang=zh_cn&edition=full","pubTime":"2026-05-31 04:51","pubTimestamp":1780174268,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，南京医药报收于5.01元，较上周的5.12元下跌2.15%。本周，南京医药5月25日盘中最高价报5.1元。本周关注点公司公告汇总：南京医药拟出资不超过45,000万元参与设立大清并购基金，用于收购大清生物及科健科技股权。此前同类现金管理已到期赎回，本金7,500万元及收益48.75万元均已收回。药品零售板块2025年销售额27.35亿元，同比增长7.5%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100001533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0209","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638166157","title":"南京医药（600713）披露召开2026年第三次临时股东会提示性公告，5月28日股价下跌0.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638166157","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638166157?lang=zh_cn&edition=full","pubTime":"2026-05-28 17:34","pubTimestamp":1779960867,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘，南京医药报收于4.93元，较前一交易日下跌0.8%，最新总市值为64.53亿元。该股当日开盘4.95元，最高4.99元，最低4.88元，成交额达3912.33万元，换手率为0.62%。近日，南京医药集团股份有限公司发布《关于召开2026年第三次临时股东会的提示性公告》。公告显示，公司将于2026年6月8日召开2026年第三次临时股东会，会议采取现场投票与网络投票相结合方式，股权登记日为2026年5月28日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800031577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713","BK0209","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638543762","title":"南京医药（600713）披露拟设立大清并购基金并收购大清生物及科健科技股权，5月26日股价下跌0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638543762","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638543762?lang=zh_cn&edition=full","pubTime":"2026-05-26 22:44","pubTimestamp":1779806660,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，南京医药报收于5.03元，较前一交易日下跌0.59%，最新总市值为65.84亿元。该股当日开盘5.05元，最高5.05元，最低5.0元，成交额达4808.49万元，换手率为0.74%。近日，南京医药发布2026年第三次临时股东会材料。公告显示，公司拟出资不超过45,000万元，与新工产投、新工医疗并购基金共同设立大清并购基金，专项用于收购大清生物44.95%股权和科健科技50.98%股权，并购总金额74,738.9944万元，交易完成后纳入公司合并报表范围。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600041454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","600713","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637737542","title":"每周股票复盘：南京医药（600713）拟出资4.5亿参与设立大清并购基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2637737542","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637737542?lang=zh_cn&edition=full","pubTime":"2026-05-24 03:59","pubTimestamp":1779566348,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，南京医药报收于5.12元，较上周的5.23元下跌2.1%。本周关注点公司公告汇总：南京医药拟出资不超过45,000万元参与设立大清并购基金。公司公告汇总：南京医药将于2026年6月8日召开第三次临时股东会，审议设立大清并购基金等议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637332717","title":"南京医药（600713）披露召开2026年第三次临时股东会的通知，5月21日股价下跌1.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637332717","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637332717?lang=zh_cn&edition=full","pubTime":"2026-05-21 22:33","pubTimestamp":1779373992,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，南京医药报收于5.0元，较前一交易日下跌1.96%，最新总市值为65.44亿元。该股当日开盘5.08元，最高5.13元，最低5.0元，成交额达5863.52万元，换手率为0.9%。近日，南京医药集团股份有限公司发布《关于召开2026年第三次临时股东会的通知》。公告显示，公司定于2026年6月8日召开2026年第三次临时股东会，会议采取现场投票与网络投票相结合的方式，股权登记日为2026年5月28日。两项议案均涉及关联股东回避表决，并对中小投资者单独计票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100044603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713","BK0250","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637813033","title":"南京医药最新公告：拟出资不超4.5亿元设立并购基金专项收购大清生物及科健科技股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2637813033","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637813033?lang=zh_cn&edition=full","pubTime":"2026-05-21 17:40","pubTimestamp":1779356401,"startTime":"0","endTime":"0","summary":"南京医药(600713.SH)公告称，公司拟出资不超过4.5亿元，与新工产投、新工医疗并购基金共同投资设立大清并购基金。该基金成立后将专项用于并购大清生物44.95%股权和科健科技50.98%股权，并购总金额为7.47亿元。交易完成后，大清并购基金、大清生物、科健科技将纳入公司合并报表范围。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100032503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","600713","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637381578","title":"南京医药(600713.SH)拟通过并购基金投资生物材料和再生医学领域平台型研发公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2637381578","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637381578?lang=zh_cn&edition=full","pubTime":"2026-05-21 17:22","pubTimestamp":1779355326,"startTime":"0","endTime":"0","summary":"智通财经APP讯，南京医药 发布公告，公司拟出资不超过4.5亿元，与南京新工新兴产业投资管理有限公司、南京新工医疗健康强链并购股权投资基金合伙企业共同投资设立南京医药集团大清医疗器械强链并购股权投资有限责任公司。据悉，并购标的属于生物材料和再生医学领域平台型研发公司，主要产品为植入类生物材料，拥有外科止血材料和骨修复材料核心产品，围绕生物材料和再生医学领域建立了多种材料制备技术平台。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444527.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0250","BK0209","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636384388","title":"南京医药（600713）披露终止对外投资公告，5月20日股价下跌2.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636384388","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636384388?lang=zh_cn&edition=full","pubTime":"2026-05-20 17:55","pubTimestamp":1779270914,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，南京医药报收于5.1元，较前一交易日下跌2.3%，最新总市值为66.75亿元。该股当日开盘5.2元，最高5.2元，最低5.09元，成交额达5334.56万元，换手率为0.81%。南京医药于2026年5月20日发布《关于终止对外投资的公告》。因另一投资方拟以8亿元估值受让江丰生物22.5%股权，公司及合作方于2026年5月7日发函确认投资意向，截至5月18日未获江丰生物书面回复。公告同时指出，本次终止不影响公司正常经营及财务状况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000034507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636629950","title":"每周股票复盘：南京医药（600713）将召开2025年年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2636629950","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636629950?lang=zh_cn&edition=full","pubTime":"2026-05-17 04:30","pubTimestamp":1778963432,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，南京医药报收于5.23元，较上周的5.35元下跌2.24%。本周，南京医药5月12日盘中最高价报5.44元。南京医药当前最新总市值68.46亿元，在医药商业板块市值排名15/32，在两市A股市值排名2806/5203。本周关注点公司公告汇总：南京医药将于2026年5月26日召开2025年年度暨2026年第一季度业绩说明会。投资者可于2026年5月19日至5月25日16:00前通过上证路演中心网站或公司邮箱600713@njyy.com提问。会议结束后，投资者可通过上证路演中心查看会议情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635715819","title":"南京医药（600713）披露召开2025年年度暨2026年第一季度业绩说明会公告，5月14日股价下跌1.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635715819","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635715819?lang=zh_cn&edition=full","pubTime":"2026-05-14 18:16","pubTimestamp":1778753779,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，南京医药报收于5.27元，较前一交易日下跌1.13%，最新总市值为68.98亿元。该股当日开盘5.31元，最高5.33元，最低5.19元，成交额达1.17亿元，换手率为1.73%。南京医药于近日发布《关于召开2025年年度暨2026年第一季度业绩说明会的公告》。公告显示，公司将于2026年5月26日13:00-14:45通过上证路演中心召开2025年年度暨2026年第一季度业绩说明会，介绍公司2025年度及2026年第一季度的经营成果和财务状况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400034800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","600713","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634412612","title":"每周股票复盘：南京医药（600713）2025年年度股东会顺利召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2634412612","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634412612?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:26","pubTimestamp":1778354771,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，南京医药报收于5.35元，较上周的5.28元上涨1.33%。本周，南京医药5月8日盘中最高价报5.37元。本周关注点公司公告汇总：南京医药2025年年度股东会审议通过利润分配预案、续聘审计机构等多项议案。公司公告汇总南京医药集团股份有限公司于2026年5月8日召开2025年年度股东会，由董事会召集，董事长周建军主持，出席会议的股东及代理人共552人，代表有表决权股份总数的59.2982%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0209","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633457072","title":"南京医药（600713）披露2025年年度股东会决议公告，5月8日股价上涨0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633457072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633457072?lang=zh_cn&edition=full","pubTime":"2026-05-08 22:34","pubTimestamp":1778250853,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，南京医药报收于5.35元，较前一交易日上涨0.94%，最新总市值为70.03亿元。该股当日开盘5.29元，最高5.37元，最低5.29元，成交额达9986.3万元，换手率为1.45%。南京医药集团股份有限公司于2026年5月8日召开2025年年度股东会，会议由董事会召集，董事长周建军主持，出席会议的股东及代理人共552人，代表有表决权股份总数的59.2982%。控股股东对第7项议案回避表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800043817.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","600713","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632441866","title":"每周股票复盘：南京医药（600713）一季度营收138.44亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2632441866","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632441866?lang=zh_cn&edition=full","pubTime":"2026-05-02 03:15","pubTimestamp":1777662913,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，南京医药报收于5.28元，较上周的5.53元下跌4.52%。业绩披露要点：2026年一季度主营收入138.44亿元，同比下降2.83%。股本股东变化股东户数变动截至2026年3月31日，南京医药股东户数为4.75万户，较12月31日减少1741.0户，减幅为3.54%。公司公告汇总南京医药2026年第一季度报告南京医药2026年第一季度实现营业收入13,843,779,763.60元，同比下降2.83%；利润总额281,917,557.90元，同比增长2.02%；归属于上市公司股东的净利润174,569,585.50元，同比下降1.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200000673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632667153","title":"南京医药（600713）2026年一季报简析：净利润同比下降1.57%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2632667153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632667153?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:14","pubTimestamp":1777587262,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期南京医药发布2026年一季报。截至本报告期末，公司营业总收入138.44亿元，同比下降2.83%，归母净利润1.75亿元，同比下降1.57%。本报告期南京医药盈利能力上升，毛利率同比增幅5.34%，净利率同比增幅1.06%。去年的净利率为1.51%，算上全部成本后，公司产品或服务的附加值不高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100004734.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631548718","title":"南京医药（600713）披露增加2026年度日常关联交易预计公告，4月29日股价上涨0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631548718","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631548718?lang=zh_cn&edition=full","pubTime":"2026-04-29 22:17","pubTimestamp":1777472276,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘，南京医药报收于5.44元，较前一交易日上涨0.18%，最新总市值为71.2亿元。近日，南京医药集团股份有限公司披露《关于增加2026年度日常关联交易预计的公告》。因第二大股东变更，公司新增广州白云山医药集团股份有限公司及下属子公司、南京南药活力蚂蚁门诊部有限公司为关联方，增加2026年度日常关联交易预计金额合计50,200万元。关联交易遵循市场定价原则，不影响公司独立性，不存在损害股东利益情形。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900068827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","600713","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631515828","title":"图解南京医药一季报：第一季度单季净利润同比下降1.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631515828","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631515828?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:33","pubTimestamp":1777462392,"startTime":"0","endTime":"0","summary":"证券之星消息，南京医药2026年一季报显示，一季度公司主营收入138.44亿元，同比下降2.83%；归母净利润1.75亿元，同比下降1.57%；扣非净利润1.69亿元，同比下降0.39%；负债率76.16%，投资收益-143.33万元，财务费用1.07亿元，毛利率6.28%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900060164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628756797","title":"每周股票复盘：南京医药（600713）子公司5000万闲置募资买大额存单","url":"https://stock-news.laohu8.com/highlight/detail?id=2628756797","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628756797?lang=zh_cn&edition=full","pubTime":"2026-04-19 02:07","pubTimestamp":1776535627,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，南京医药报收于5.99元，较上周的6.05元下跌0.99%。本周，南京医药4月13日盘中最高价报6.65元，股价触及近一年最高点。本周关注点公司公告汇总：子公司福建同春使用5000万元闲置募集资金购买招商银行大额存单，年化收益率1.10%。此前5,000万元大额存单已到期赎回，获得收益13.75万元。报告期内，南京医药向不特定对象发行可转换公司债券，募集资金净额1,069,040,922.31元，于2025年1月20日上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626120473","title":"南京医药（600713）2025年年报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2626120473","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626120473?lang=zh_cn&edition=full","pubTime":"2026-04-12 06:02","pubTimestamp":1775944923,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期南京医药发布2025年年报。根据财报显示，南京医药营收净利润同比双双增长。截至本报告期末，公司营业总收入549.63亿元，同比上升2.36%，归母净利润6.25亿元，同比上升9.5%。按单季度数据看，第四季度营业总收入138.28亿元，同比上升8.39%，第四季度归母净利润2.23亿元，同比上升73.1%。本次财报公布的各项数据指标表现尚佳。去年的净利率为1.51%，算上全部成本后，公司产品或服务的附加值不高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041200000801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780993458927,"stockEarnings":[{"period":"1week","weight":-0.0391},{"period":"1month","weight":-0.0804},{"period":"3month","weight":-0.0804},{"period":"6month","weight":-0.0734},{"period":"1year","weight":-0.0201},{"period":"ytd","weight":-0.0989}],"compareEarnings":[{"period":"1week","weight":-0.0242},{"period":"1month","weight":-0.0528},{"period":"3month","weight":-0.0397},{"period":"6month","weight":0.0151},{"period":"1year","weight":0.1695},{"period":"ytd","weight":-0.0024}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京医药集团股份有限公司","boardCode":"AI0052","boardName":"零售业","stockholders":"47508人(较上一季度减少3.54%)","perCapita":"27149股","listingDate":"1996-07-01","address":"江苏省南京市雨花台区安德门大街55号2幢","registeredCapital":"130889万元","survey":" 南京医药集团股份有限公司的主营业务是药品配送、批发、零售及医疗器械配送、批发、医药物流服务和互联网药品零售。公司的主要产品是医药批发、医药零售、医药“互联网+”、医药第三方物流服务。公司现居2024年国内医药流通行业规模排名第7位；2025年《财富》中国500强第307位，较上年排名上升11位。公司亦曾荣获“全国医药流通创新示范企业”称号，是第一批“全国供应链创新与应用示范企业”。","listedPrice":5.98},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"南京医药(600713)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供南京医药(600713)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"南京医药,600713,南京医药股票,南京医药股票老虎,南京医药股票老虎国际,南京医药行情,南京医药股票行情,南京医药股价,南京医药股市,南京医药股票价格,南京医药股票交易,南京医药股票购买,南京医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"南京医药(600713)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供南京医药(600713)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}